Company Filing History:
Years Active: 1997-1999
Title: Lena Dillner: Innovator in Papillomavirus Diagnostics
Introduction
Lena Dillner is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of medical diagnostics, particularly in the detection of human papillomavirus (HPV). With a total of 2 patents, her work has had a substantial impact on public health.
Latest Patents
Lena's latest patents include innovative methods for diagnosing infections related to human papillomaviruses. One of her notable inventions focuses on synthetic peptides in HPV types 1, 5, 6, 8, 11, 16, 18, and 31. This invention refers to a method for diagnosing the presence of papillomavirus infections, particularly those associated with cervical cancer and condyloma, through the detection of virus-specific antigen-antibody complexes in immunoassays. Another patent involves a method for the detection of HPV for diagnostic purposes, further enhancing the capabilities of medical professionals in identifying and treating HPV-related conditions.
Career Highlights
Throughout her career, Lena Dillner has worked with reputable companies such as Euro-Diagnostica AB and Ferring AB. Her experience in these organizations has allowed her to develop and refine her innovative diagnostic methods, contributing to advancements in the medical field.
Collaborations
Lena has collaborated with esteemed colleagues, including Joakim Dillner and Hwee-Ming Cheng. These partnerships have fostered a collaborative environment that has led to significant advancements in HPV research and diagnostics.
Conclusion
Lena Dillner's contributions to the field of papillomavirus diagnostics exemplify her dedication to improving public health through innovation. Her patents and collaborations highlight her role as a leading inventor in this critical area of medical research.